Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling

Lei Zhang, Qiaoling Song, Xinxin Zhang, Li Li, Ximing Xu, Xiaohan Xu, Xiaoyu Li, Zhuoya Wang, Yuxi Lin, Xin Li,

Investigational New Drugs · 2019 · 17 citations · 22 references

Concepts

References

22